Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy
- PMID: 38103076
- DOI: 10.1007/s00595-023-02779-6
Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy
Abstract
Purpose: The association between perioperative and post-adjuvant carcinoembryonic antigen (CEA) levels and recurrence and prognosis remains unclear. We aimed to evaluate whether perioperative CEA levels are an integral component of the assessment of recurrence and prognosis of patients with stage III colon cancer (CC).
Methods: This retrospective study was conducted at the Cancer Institute Hospital of the Japanese Foundation for Cancer Research from 2005 to 2013. We enrolled patients with stage III CC who underwent complete resection of a primary tumor and received adjuvant chemotherapy. We analyzed the association between perioperative and post-adjuvant CEA levels and recurrence-free survival (RFS) and overall survival (OS).
Results: A total of 564 consecutive patients were included in the analysis. The RFS and OS of patients with high postoperative CEA levels were significantly worse than those of patients with normal postoperative CEA levels. In the multivariate analysis, high postoperative CEA levels were associated with shorter RFS and OS. The number of risk factors, postoperative CEA levels, and T/N-stage all had a cumulative effect on RFS and OS.
Conclusions: High postoperative CEA levels and the number of risk factors are associated with recurrence and worse prognosis for patients with stage III CC.
Keywords: Carcinoembryonic antigen; Colonic neoplasms; Postoperative period; Recurrence; Risk.
© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.
Similar articles
-
Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancer.Am J Surg. 2025 May;243:116256. doi: 10.1016/j.amjsurg.2025.116256. Epub 2025 Feb 19. Am J Surg. 2025. PMID: 40015199
-
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.Ann Surg Oncol. 2017 Jan;24(1):227-235. doi: 10.1245/s10434-016-5613-5. Epub 2016 Oct 3. Ann Surg Oncol. 2017. PMID: 27699609
-
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.JAMA Oncol. 2018 Mar 1;4(3):309-315. doi: 10.1001/jamaoncol.2017.4420. JAMA Oncol. 2018. PMID: 29270608 Free PMC article.
-
Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.Sci Rep. 2024 Mar 22;14(1):6889. doi: 10.1038/s41598-024-55967-w. Sci Rep. 2024. PMID: 38519578 Free PMC article.
-
Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.Eur J Surg Oncol. 2021 Nov;47(11):2880-2887. doi: 10.1016/j.ejso.2021.05.041. Epub 2021 Jun 2. Eur J Surg Oncol. 2021. PMID: 34103245
Cited by
-
Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients.Surg Today. 2025 Apr 23. doi: 10.1007/s00595-025-03044-8. Online ahead of print. Surg Today. 2025. PMID: 40266400
References
-
- World Health Organization. Cancer today. 2020. https://gco.iarc.fr/today/home . Accessed 24 May 2023.
-
- Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31:4465–70. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources